A Compelling Case for Building Confidence in Data

January 6, 2025

Data validation ensures clinical registry data are consistent, accurate, and complete, and that the data conform to business rules so that insights gained from the data are based on meaningful information and can confidently be used for downstream purposes such as population health analytics, business intelligence, and training machine learning models. 

Given the ever-increasing number and complexity of clinical data sources, in-house teams, despite their expertise, may face challenges in accurately evaluating the validity of the data due to competing priorities and resource limitations. Independent validation provided by third-party experts adds a layer of objective assessment to the data validation process and ensures data validation standards and practices are rigorously adhered to. It can also identify issues that internal teams may miss. 

The return on investment can be viewed in terms of both cost savings and streamlining processes. Through third-party validation and implementing improvements, clinical registries can realize increased efficiency and improved decision making, as well as stakeholder confidence.

Contact us at info@adventadvisorygroup.com for a copy of our white paper on Independent Validation of Clinical Registries.


Advent Advisory Group Insights

HEDIS® 2026 Public Comment Period: Key Takeaways and Impact Analysis
February 19, 2026
NCQA has opened the 2026 HEDIS® Public Comment period, running from February 13 through March 13, 2026.
CMS Releases CY 2027 Advance Notice: Key Considerations for Medicare Advantage Plans
January 30, 2026
CMS has released its CY 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.
November 25, 2025
The CMS 2026 Program Audit Annual Updates bring several important changes that healthcare sponsors must address to stay compliant. These updates affect various aspects of the audit process, from condition classifications to new requirements for validation audits.
November 13, 2025
Aside from the usual updates to the audit timeline and other wording changes, this year’s HEDIS audit manual includes several changes of significance.
October 21, 2025
The Advent team had the opportunity to attend the NCQA Health Innovation Summit, where healthcare leaders and innovators came together to explore the next phase of digital quality measurement and value-based care.
October 16, 2025
HEDIS is shifting. Stars are flattening. Advantage goes to plans that act now. After several consecutive years of declines, the average Medicare Advantage (MA) Star Ratings are essentially flat for 2026.
October 10, 2025
As California leaders assess the sweeping implications of these proposed changes, Advent Advisory Group is helping health plans evaluate exposure, model financial impacts, and prepare operational strategies across Medicare, Medi-Cal, and Commercial lines.
Turning NCQA 2025 Health Plan Ratings into a Roadmap for Improvement
September 19, 2025
The 2025 NCQA Health Plan Ratings are out. For health plans, these results are more than just numbers — they’re a public reflection of quality, experience, and performance.
Tips for a Better CMS Program Audit Experience
August 26, 2025
CMS recently published its annual Part C and Part D Program Audit and Enforcement Report. The report provided recommendations and guidance for Sponsors to consider when preparing for future CMS Program Audits.
August 7, 2025
Advent’s HEDIS 2026 webinar series kicked off last month with Optimizing Clinical Data Quality, a presentation focused on common challenges with supplemental clinical data. Key takeaways include the following:  Transition in Data Collection: The shift from manual data collection to digital HEDIS reporting has increased the focus on clinical data over claims data. NCQA’s planned elimination of the hybrid reporting method has added urgency to this transition, driving plans to acquire more electronic clinical data and adapt to year-round ingestion. Challenges with Clinical Data: The presentation highlighted several challenges to the acquisition of supplemental clinical data, including data timing, completeness, and accuracy. Issues such as short turnaround times, missing biometric values, and incorrect coding have impacted the useability of these additional data sources for HEDIS reporting. Tips for Navigating the Transition: Plans can navigate this transition by starting early with clinical data validation, engaging with IT departments, exploring vendor’s reports and supportive capabilities, and building executive leadership buy-in.
More Posts